Vaso Corporation Appoints Shaun McMeans to Board of Directors

Rhea-AI Summary

Vaso Corporation (OTCQX: VASO) has appointed Shaun McMeans to its Board of Directors, effective July 23, 2026. McMeans is currently CFO of Nabsys and previously served as CFO of HTG Molecular Diagnostics, bringing extensive finance, accounting and operational leadership experience across life sciences and technology sectors.

News Market Reaction – VASO

-0.36%

-0.36% Session close to close

In the Jul 24 session, VASO declined 0.36%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PLAINVIEW, N.Y., July 23, 2026 (GLOBE NEWSWIRE) -- Vaso Corporation (“Vaso”) (OTCQX: VASO), a leading MedTech company with a diversified business portfolio in network and IT services, professional sales services and proprietary medical products, today announced the appointment of Shaun McMeans to the Company’s Board of Directors, effective July 23, 2026.

“We are pleased to welcome Shaun to Vaso’s Board of Directors,” said Dr. Jun Ma, President and Chief Executive Officer of Vaso Corporation. “Shaun brings substantial public company finance, accounting and operational leadership experience in the life sciences and technology sectors. We believe his background will be valuable to Vaso as we continue to execute our strategic initiatives and pursue long-term value for our stockholders.”

Mr. McMeans currently serves as Chief Financial Officer of Nabsys, a life sciences technology company, where he leads finance and administrative functions. From 2012 through 2023, Mr. McMeans served as Chief Financial Officer of HTG Molecular Diagnostics, Inc., a publicly traded life science tools and diagnostics company. Prior to joining HTG Molecular Diagnostics, Mr. McMeans held senior finance and accounting roles with Securaplane Technologies, Inc., Tatum LLC, The Long Companies, LXU Healthcare, Inc. and Burnham Holdings, Inc. Mr. McMeans received a B.S. in Accounting from The Pennsylvania State University.

About Vaso

Vaso Corporation is a leading MedTech company with a diversified business portfolio in network and IT services, professional sales services and proprietary medical products. The Company operates through three principal business segments: IT, professional sales services and equipment.

Forward-Looking Statements

This press release may contain forward-looking statements within the meaning of the federal securities laws. These statements are based on current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Vaso undertakes no obligation to update any forward-looking statements except as required by law.

Investor Contact:
Jonathan Newton
Investor Relations
Phone: 516-997-4600
Email: jnewton@vasocorporation.com 

FAQ

What board change did Vaso Corporation (OTCQX: VASO) announce on July 23, 2026?

Vaso Corporation announced the appointment of Shaun McMeans to its Board of Directors, effective July 23, 2026. According to Vaso, McMeans adds public company finance, accounting and operational leadership experience in the life sciences and technology sectors to support the company’s strategic initiatives.

Who is Shaun McMeans, newly appointed to the Vaso (VASO) Board of Directors?

Shaun McMeans is a finance executive currently serving as Chief Financial Officer of Nabsys. According to Vaso, he previously was CFO of HTG Molecular Diagnostics from 2012 to 2023 and has held senior finance and accounting roles at several technology and healthcare-related companies.

What experience does Vaso’s new director Shaun McMeans bring to the VASO board?

Shaun McMeans brings substantial public company finance, accounting and operational leadership experience. According to Vaso, his background spans life sciences tools, diagnostics and technology companies, including CFO roles and senior finance positions, which the company believes will support execution of its strategic initiatives and long-term stockholder value goals.

What is Shaun McMeans’ current role outside his position on Vaso’s (VASO) board?

Shaun McMeans currently serves as Chief Financial Officer of Nabsys, a life sciences technology company. According to Vaso, he leads finance and administrative functions there, complementing his prior CFO role at HTG Molecular Diagnostics and other senior finance and accounting positions.

What is the educational background of Vaso director Shaun McMeans (VASO)?

Shaun McMeans holds a B.S. in Accounting from The Pennsylvania State University. According to Vaso, this accounting foundation has underpinned his career in finance leadership positions across multiple life sciences, technology, healthcare and industrial companies, culminating in his current CFO and new board responsibilities.